IPO Pops Are Packing A Lot Less Punch

Earlier this year it was almost a given that companies going public were in for a big share price “pop” on their first day of trading. Now, a “snap” or “crackle” is a real possibility. New figures released Tuesday show…

Jennifer
Image Credit: iStock Images, Andrey Krav.
Sign up for insightful business news.

Earlier this year it was almost a given that companies going public were in for a big share price “pop” on their first day of trading. Now, a “snap” or “crackle” is a real possibility.

New figures released Tuesday show investors are pumping the breaks on investments in U.S. initial public offerings, turning some high-profile debuts into flops.

Winner’s Quarter

During a piping hot first quarter of generally bullish markets, an IPO stock listing on U.S. exchanges was close to what Vegas would call “a sure thing”:

  • Companies listed on the New York Stock Exchange or Nasdaq in January and February rose an average of 40% from their IPO price on day one of trading, according to Dealogic.
  • But through March and April, that average first-day pop fell to 20%. Last month, it dipped to 18%.

“It’s just not the ‘everybody’s a winner’ market that it was in the first quarter,” said Rachel Phillips, a capital markets lawyer at Ropes & Gray’s. And shaky market conditions, like increasingly choppy equity trading, have led firms to adjust their playbooks:

  • Some are getting gun-shy on pricing: since the start of the second quarter, 13% of companies going public via IPO priced below expectations, the highest since the start of the pandemic. While 25% priced above expectations in the first quarter, only 11% are doing so now.
  • Others pressed pause on their plans: Genworth Financial, scheduled to spin off its mortgage insurance business Enact last month, postponed the IPO after inflation concerns dragged down shares in the sector by 10%.

Debut Duds: While most companies are still rising on their debut, several big IPOs in the last few weeks have been full-on flops. Chinese insurance tech group Waterdrop fell 19% on its first trading day. Vaccitech, a biotech firm that owns the technology that created the Oxford/AstraZeneca coronavirus vaccine, dropped 17% on its first day.

Krispy Lining: At least one big name remains hungry to hit public markets. Donut maker Krispy Kreme announced Tuesday that, five years after it went private, it’s planning an IPO. The ticker symbol: DNUT.

Analysis more
(Photo Credit: Towfiqu Barbhuiya/Unsplash)

Private Practice: A Q&A with Pierre Valade, Founder of Privacy App Jumbo

(Photo Credit: Nate DeWaele/Unsplash)

The Brontosaurus Bubble: Could the bottom fall out of the dinosaur fossil market?

Recent News

Southwest Reducing Training Time Needed for New Pilots

Absolutely Nobody Can Agree on What’s Happening With the Economy Right Now

America’s Push for EVs Could Leave the Power Grid Feeling Drained

Private Practice: A Q&A with Pierre Valade, Founder of Privacy App Jumbo